FXR ligands protect against hepatocellular inflammation via SOCS3 induction

Zhizhen Xu1, Gang Huang, Wei Gong

  • 1Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Third Military Medical University, Chongqing 400038, China.

Insights

Farnesoid X receptor (FXR) agonists reduce liver inflammation by increasing suppressor of cytokine signaling 3 (SOCS3) expression. This mechanism may offer new treatments for liver inflammatory diseases.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Immunology

Background:

  • Farnesoid X receptor (FXR) agonists exhibit anti-inflammatory properties, making FXR a potential therapeutic target for liver diseases.
  • The precise molecular mechanisms underlying FXR's anti-inflammatory actions remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which FXR activation exerts anti-inflammatory effects in liver injury.
  • To investigate the role of suppressor of cytokine signaling 3 (SOCS3) in mediating FXR's protective actions.

Main Methods:

  • Utilized an animal model of lipopolysaccharide (LPS)-induced liver injury.
  • Administered CDCA (a natural FXR ligand) and GW4064 (a synthetic FXR ligand).
  • Assessed inflammatory markers, transaminase activities, STAT3 phosphorylation, and SOCS3 expression; employed small interfering RNA (siRNA) for SOCS3 knockdown.

Main Results:

  • CDCA administration attenuated hepatocyte inflammatory damage and reduced liver injury markers in LPS-treated mice.
  • FXR activation suppressed key inflammation mediators (IL-6, TNF-α, ICAM-1) and inhibited STAT3 phosphorylation.
  • These protective effects correlated with increased SOCS3 expression, a negative regulator of cytokine-STAT3 signaling. SOCS3 knockdown diminished FXR's beneficial effects on STAT3 activation. Both natural and synthetic FXR ligands upregulated SOCS3 expression by enhancing its promoter activity.

Conclusions:

  • FXR activation protects against liver inflammation, at least partly, through the induction of SOCS3.
  • Modulation of SOCS3 expression represents a novel mechanism for FXR's anti-inflammatory effects.
  • FXR ligands hold therapeutic potential for treating liver inflammatory diseases by inducing SOCS3.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...